This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As nuclearmedicine therapies gain stature compared to nuclearmedicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclearmedicine technologists means a theranostics center may need to limit its patient volume.
Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclearmedicine, diagnostic radiology, and radiationoncology.
Even if some private urology, radiationoncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. Theranostics is becoming a treatment option for a larger volume of cancer patients. Hope added.
reduction in average Medicare payment rates compared with 2024, the CMS has estimated there will be a 0% change to reimbursement for radiology, nuclearmedicine, and radiationoncology. The American Society for RadiationOncology (ASTRO) was disappointed in the final MPFS rule.
In a comparative imaging trial, fibroblast activation protein inhibitor (FAPI)-PET/CT outperformed FDG-PET/CT in detecting primary tumors in patients with head and neck cancer, according to a study published January 25 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
F-18 FAPI-PET/CT is superior to F-18 FDG-PET/CT for diagnosing and staging patients with pancreatic cancer, according to a study published January 4 in the Journal of NuclearMedicine. In the future, F-18 FAPI-04 PET/CT may play a greater role in the actual clinical management of PDAC,” the group wrote.
milla1cf Thu, 09/14/2023 - 15:17 September 14, 2023 — Mayo Clinic and GE HealthCare announce a strategic healthcare collaboration for research and product development programs aimed to transform the experience of patients and clinicians in the practice of radiology and the delivery of novel therapies.
professor of the Department of RadiationOncology and the Department of Immunology and Theranostics at City of Hope , and principal investigator of the RefleXion-supported PyL imaging study. professor and chair of City of Hope’s Department of RadiationOncology. “As
Assessment of Claimant, Clinical, and Financial Characteristics of Teleradiology Medical Malpractice Cases. Luthria, et al, Journal of NuclearMedicine , October 26, 2023. Neuroimaging and Clinical Findings in Healthy Middle-Aged Adults With Mild Traumatic Brain Injury in the PREVENT Dementia Study.
No shortage is expected of Mo-99’s daughter decay chain isotope technetium-99m (Tc-99m), which is used in an estimated 40,000 diagnostic nuclearmedicine exams each day in the U.S., said the Society of NuclearMedicine and Molecular Imaging (SNMMI).
GE HealthCare expects to integrate MIM Software solutions into its advanced visualization offerings to facilitate AI-based segmentation and contouring as well as dosimetry analysis for patients across their treatment journeys and in the growing fields of radiology, molecular imaging, and radiationoncology.
and around the world, with many promising drugs in clinical trials. The Ge-68/Ga-68 generator on the other hand, is an easily transportable, small metal box and can be obtained much more cost-efficient, leading to cost reductions in nuclearmedicineclinics and practices while increasing flexibility.
Enhances TTG’s continued commitment to offer a full spectrum of high-quality and cost-effective service solutions in the cardiology and radiationoncology markets PITTSBURGH, PA (May 5, 2023) – TTG Imaging Solutions, LLC (TTG) announced today the acquisition of Digirad Health, Inc., headquartered in Suwanee, GA. Digirad Health, Inc.
These services include: CT, MRI, NuclearMedicine, Ultrasound, 3D Mammography & Women’s Imaging, Hereditary Cancer Risk and X-Ray. In July 2021, Midstate Radiology Associates, LLC. also acquired Radiology Group PC. and with the acquisition of NHRA, Whitney Imaging and Whitney Imaging West, Midstate Radiology Associates, LLC.
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. The nuclear radiologist, nuclearmedicine technologist, and radiation safety team are all present to administer an infusion.
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. The nuclear radiologist, nuclearmedicine technologist, and radiation safety team are all present to administer an infusion.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content